Authors: HOLLAND S SHAHANE A ROGERS JD PORRAS A GRASING K LASSETER K PINTO M FREEMAN A GERTZ B AMIN R

Citation: S. Holland et al., METABOLISM OF MONTELUKAST (M) IS INCREASED BY MULTIPLE DOSES OF PHENOBARBITAL (P), Clinical pharmacology and therapeutics, 63(2), 1998, pp. 99-99

Authors: THYRUM PT YEH C BIRMINGHAM B LASSETER K

Citation: Pt. Thyrum et al., PHARMACOKINETICS OF MEROPENEM IN PATIENTS WITH LIVER-DISEASE, Clinical infectious diseases, 24, 1997, pp. 184-190

Authors: VARGO DL WILKINSON LA LASSETER K

Citation: Dl. Vargo et al., EFFECT OF ZAFIRLUKAST ON THE PHARMACOKINETICS OF R-WARFARIN AND S-WARFARIN IN HEALTHY-MEN, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 86-86

Authors: HUANG SM BRUSSER L CHIEN SC SIMON D SMITH IL ABRAMS LS LASSETER K

Citation: Sm. Huang et al., PHARMACOKINETICS AND BIOAVAILABILITY OF BEMORADAN, A LONG-ACTING INODILATOR IN HEALTHY-MALES, International journal of clinical pharmacology and therapeutics, 32(2), 1994, pp. 62-64

Authors: SCHWARTZ J CHENG H PIPKIN J LARSON P LASSETER K

Citation: J. Schwartz et al., COMPARISON OF CONTROLLED-RELEASE VS CONVENTIONAL LOVASTATIN FORMULATIONS, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 187-187